nodes	percent_of_prediction	percent_of_DWPC	metapath
Flucloxacillin—CYP3A4—Temozolomide—melanoma	0.398	0.576	CbGbCtD
Flucloxacillin—CYP3A4—Vemurafenib—melanoma	0.218	0.316	CbGbCtD
Flucloxacillin—CYP3A4—Docetaxel—melanoma	0.0748	0.108	CbGbCtD
Flucloxacillin—Erythema nodosum—Vemurafenib—melanoma	0.0146	0.0501	CcSEcCtD
Flucloxacillin—Reaction gastrointestinal—Docetaxel—melanoma	0.00641	0.0221	CcSEcCtD
Flucloxacillin—Oral candidiasis—Carmustine—melanoma	0.00524	0.018	CcSEcCtD
Flucloxacillin—Oral candidiasis—Temozolomide—melanoma	0.00507	0.0174	CcSEcCtD
Flucloxacillin—Digestion impaired—Temozolomide—melanoma	0.00482	0.0166	CcSEcCtD
Flucloxacillin—Toxic epidermal necrolysis—Vemurafenib—melanoma	0.00412	0.0142	CcSEcCtD
Flucloxacillin—Eosinophilia—Vemurafenib—melanoma	0.00391	0.0135	CcSEcCtD
Flucloxacillin—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.00349	0.012	CcSEcCtD
Flucloxacillin—Oral candidiasis—Docetaxel—melanoma	0.00337	0.0116	CcSEcCtD
Flucloxacillin—Candida infection—Carmustine—melanoma	0.00318	0.0109	CcSEcCtD
Flucloxacillin—Heartburn—Docetaxel—melanoma	0.00311	0.0107	CcSEcCtD
Flucloxacillin—Connective tissue disorder—Vemurafenib—melanoma	0.00311	0.0107	CcSEcCtD
Flucloxacillin—Candida infection—Temozolomide—melanoma	0.00307	0.0106	CcSEcCtD
Flucloxacillin—Erythema multiforme—Vemurafenib—melanoma	0.00299	0.0103	CcSEcCtD
Flucloxacillin—Throat sore—Docetaxel—melanoma	0.00297	0.0102	CcSEcCtD
Flucloxacillin—Oropharyngeal discomfort—Docetaxel—melanoma	0.00294	0.0101	CcSEcCtD
Flucloxacillin—Oxacillin—SLC15A2—melanoma	0.00287	0.155	CrCbGaD
Flucloxacillin—Dysgeusia—Vemurafenib—melanoma	0.0027	0.00928	CcSEcCtD
Flucloxacillin—Cyclacillin—SLC15A2—melanoma	0.00266	0.143	CrCbGaD
Flucloxacillin—Vascular purpura—Temozolomide—melanoma	0.00261	0.00899	CcSEcCtD
Flucloxacillin—Purpura—Temozolomide—melanoma	0.00242	0.00834	CcSEcCtD
Flucloxacillin—Azidocillin—SLC15A2—melanoma	0.00236	0.127	CrCbGaD
Flucloxacillin—Bronchospasm—Bleomycin—melanoma	0.00235	0.0081	CcSEcCtD
Flucloxacillin—Oropharyngeal pain—Docetaxel—melanoma	0.00235	0.0081	CcSEcCtD
Flucloxacillin—Arthralgia—Vemurafenib—melanoma	0.00234	0.00806	CcSEcCtD
Flucloxacillin—Myalgia—Vemurafenib—melanoma	0.00234	0.00806	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00233	0.00801	CcSEcCtD
Flucloxacillin—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.00233	0.008	CcSEcCtD
Flucloxacillin—Cloxacillin—SLC15A2—melanoma	0.00227	0.122	CrCbGaD
Flucloxacillin—Dicloxacillin—SLC15A2—melanoma	0.00227	0.122	CrCbGaD
Flucloxacillin—Anaphylactic shock—Vemurafenib—melanoma	0.00225	0.00773	CcSEcCtD
Flucloxacillin—Nervous system disorder—Vemurafenib—melanoma	0.0022	0.00758	CcSEcCtD
Flucloxacillin—Skin disorder—Vemurafenib—melanoma	0.00218	0.00751	CcSEcCtD
Flucloxacillin—Toxic epidermal necrolysis—Temozolomide—melanoma	0.0021	0.00724	CcSEcCtD
Flucloxacillin—Neutropenia—Dactinomycin—melanoma	0.00209	0.00718	CcSEcCtD
Flucloxacillin—Colitis—Docetaxel—melanoma	0.00206	0.00707	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00205	0.00704	CcSEcCtD
Flucloxacillin—Candida infection—Docetaxel—melanoma	0.00204	0.00703	CcSEcCtD
Flucloxacillin—Haematuria—Bleomycin—melanoma	0.00204	0.007	CcSEcCtD
Flucloxacillin—Amoxicillin—SLC15A2—melanoma	0.00203	0.11	CrCbGaD
Flucloxacillin—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.00197	0.00679	CcSEcCtD
Flucloxacillin—Neutropenia—Carmustine—melanoma	0.00195	0.00672	CcSEcCtD
Flucloxacillin—Decreased appetite—Vemurafenib—melanoma	0.00195	0.00672	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Vemurafenib—melanoma	0.00194	0.00667	CcSEcCtD
Flucloxacillin—Constipation—Vemurafenib—melanoma	0.00192	0.00661	CcSEcCtD
Flucloxacillin—Neutropenia—Temozolomide—melanoma	0.00189	0.0065	CcSEcCtD
Flucloxacillin—Agranulocytosis—Dactinomycin—melanoma	0.00186	0.00639	CcSEcCtD
Flucloxacillin—Renal failure—Carmustine—melanoma	0.00183	0.0063	CcSEcCtD
Flucloxacillin—Ampicillin—SLC15A2—melanoma	0.0018	0.0972	CrCbGaD
Flucloxacillin—Hepatitis—Dactinomycin—melanoma	0.00179	0.00615	CcSEcCtD
Flucloxacillin—Stevens-Johnson syndrome—Temozolomide—melanoma	0.00179	0.00614	CcSEcCtD
Flucloxacillin—Body temperature increased—Vemurafenib—melanoma	0.00178	0.00611	CcSEcCtD
Flucloxacillin—Hepatobiliary disease—Temozolomide—melanoma	0.0017	0.00586	CcSEcCtD
Flucloxacillin—Erythema multiforme—Dactinomycin—melanoma	0.00169	0.00581	CcSEcCtD
Flucloxacillin—Hypersensitivity—Vemurafenib—melanoma	0.00166	0.0057	CcSEcCtD
Flucloxacillin—Connective tissue disorder—Carmustine—melanoma	0.00164	0.00565	CcSEcCtD
Flucloxacillin—Hepatitis—Temozolomide—melanoma	0.00162	0.00556	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Temozolomide—melanoma	0.0016	0.00549	CcSEcCtD
Flucloxacillin—Connective tissue disorder—Temozolomide—melanoma	0.00159	0.00546	CcSEcCtD
Flucloxacillin—Urethral disorder—Temozolomide—melanoma	0.00158	0.00545	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Bleomycin—melanoma	0.00155	0.00532	CcSEcCtD
Flucloxacillin—Anaemia—Bleomycin—melanoma	0.00154	0.0053	CcSEcCtD
Flucloxacillin—Diarrhoea—Vemurafenib—melanoma	0.00154	0.00529	CcSEcCtD
Flucloxacillin—Erythema multiforme—Temozolomide—melanoma	0.00153	0.00526	CcSEcCtD
Flucloxacillin—Malaise—Bleomycin—melanoma	0.0015	0.00518	CcSEcCtD
Flucloxacillin—Leukopenia—Bleomycin—melanoma	0.00149	0.00514	CcSEcCtD
Flucloxacillin—Dizziness—Vemurafenib—melanoma	0.00149	0.00511	CcSEcCtD
Flucloxacillin—Immune system disorder—Temozolomide—melanoma	0.00146	0.00502	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Dactinomycin—melanoma	0.00144	0.00497	CcSEcCtD
Flucloxacillin—Anaemia—Dactinomycin—melanoma	0.00144	0.00495	CcSEcCtD
Flucloxacillin—Vomiting—Vemurafenib—melanoma	0.00143	0.00492	CcSEcCtD
Flucloxacillin—Myalgia—Bleomycin—melanoma	0.00142	0.00489	CcSEcCtD
Flucloxacillin—Rash—Vemurafenib—melanoma	0.00142	0.00487	CcSEcCtD
Flucloxacillin—Dermatitis—Vemurafenib—melanoma	0.00142	0.00487	CcSEcCtD
Flucloxacillin—Headache—Vemurafenib—melanoma	0.00141	0.00484	CcSEcCtD
Flucloxacillin—Discomfort—Bleomycin—melanoma	0.0014	0.00483	CcSEcCtD
Flucloxacillin—Malaise—Dactinomycin—melanoma	0.0014	0.00483	CcSEcCtD
Flucloxacillin—Benzylpenicillin—SLC15A2—melanoma	0.0014	0.0756	CrCbGaD
Flucloxacillin—Toxic epidermal necrolysis—Docetaxel—melanoma	0.0014	0.00481	CcSEcCtD
Flucloxacillin—Leukopenia—Dactinomycin—melanoma	0.00139	0.00479	CcSEcCtD
Flucloxacillin—Dysgeusia—Temozolomide—melanoma	0.00138	0.00474	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Bleomycin—melanoma	0.00136	0.00468	CcSEcCtD
Flucloxacillin—Anaemia—Carmustine—melanoma	0.00135	0.00463	CcSEcCtD
Flucloxacillin—Nausea—Vemurafenib—melanoma	0.00133	0.00459	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Bleomycin—melanoma	0.00133	0.00459	CcSEcCtD
Flucloxacillin—Myalgia—Dactinomycin—melanoma	0.00132	0.00456	CcSEcCtD
Flucloxacillin—Bronchospasm—Docetaxel—melanoma	0.00132	0.00454	CcSEcCtD
Flucloxacillin—Discomfort—Dactinomycin—melanoma	0.00131	0.0045	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Temozolomide—melanoma	0.00131	0.00449	CcSEcCtD
Flucloxacillin—Leukopenia—Carmustine—melanoma	0.0013	0.00448	CcSEcCtD
Flucloxacillin—Anaemia—Temozolomide—melanoma	0.0013	0.00447	CcSEcCtD
Flucloxacillin—Angioedema—Temozolomide—melanoma	0.00129	0.00442	CcSEcCtD
Flucloxacillin—Malaise—Temozolomide—melanoma	0.00127	0.00437	CcSEcCtD
Flucloxacillin—Convulsion—Carmustine—melanoma	0.00126	0.00434	CcSEcCtD
Flucloxacillin—Leukopenia—Temozolomide—melanoma	0.00126	0.00433	CcSEcCtD
Flucloxacillin—Neutropenia—Docetaxel—melanoma	0.00126	0.00432	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Dactinomycin—melanoma	0.00124	0.00428	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Bleomycin—melanoma	0.00124	0.00427	CcSEcCtD
Flucloxacillin—Myalgia—Carmustine—melanoma	0.00124	0.00426	CcSEcCtD
Flucloxacillin—Convulsion—Temozolomide—melanoma	0.00122	0.00419	CcSEcCtD
Flucloxacillin—Myalgia—Temozolomide—melanoma	0.0012	0.00412	CcSEcCtD
Flucloxacillin—Arthralgia—Temozolomide—melanoma	0.0012	0.00412	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00119	0.00409	CcSEcCtD
Flucloxacillin—Stevens-Johnson syndrome—Docetaxel—melanoma	0.00119	0.00408	CcSEcCtD
Flucloxacillin—Discomfort—Temozolomide—melanoma	0.00118	0.00407	CcSEcCtD
Flucloxacillin—Decreased appetite—Bleomycin—melanoma	0.00118	0.00407	CcSEcCtD
Flucloxacillin—Renal failure—Docetaxel—melanoma	0.00118	0.00405	CcSEcCtD
Flucloxacillin—Jaundice—Docetaxel—melanoma	0.00117	0.00402	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Carmustine—melanoma	0.00116	0.004	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00116	0.00398	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Temozolomide—melanoma	0.00115	0.00395	CcSEcCtD
Flucloxacillin—Hepatobiliary disease—Docetaxel—melanoma	0.00113	0.0039	CcSEcCtD
Flucloxacillin—Nervous system disorder—Temozolomide—melanoma	0.00113	0.00387	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Temozolomide—melanoma	0.00112	0.00387	CcSEcCtD
Flucloxacillin—Feeling abnormal—Bleomycin—melanoma	0.00112	0.00386	CcSEcCtD
Flucloxacillin—Agranulocytosis—Docetaxel—melanoma	0.00112	0.00384	CcSEcCtD
Flucloxacillin—Skin disorder—Temozolomide—melanoma	0.00112	0.00384	CcSEcCtD
Flucloxacillin—Decreased appetite—Dactinomycin—melanoma	0.0011	0.0038	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Carmustine—melanoma	0.00108	0.00372	CcSEcCtD
Flucloxacillin—Urticaria—Bleomycin—melanoma	0.00108	0.00372	CcSEcCtD
Flucloxacillin—Body temperature increased—Bleomycin—melanoma	0.00108	0.0037	CcSEcCtD
Flucloxacillin—Hepatitis—Docetaxel—melanoma	0.00107	0.0037	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Docetaxel—melanoma	0.00106	0.00365	CcSEcCtD
Flucloxacillin—Connective tissue disorder—Docetaxel—melanoma	0.00106	0.00363	CcSEcCtD
Flucloxacillin—Urethral disorder—Docetaxel—melanoma	0.00105	0.00363	CcSEcCtD
Flucloxacillin—Feeling abnormal—Dactinomycin—melanoma	0.00105	0.0036	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Temozolomide—melanoma	0.00105	0.0036	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Dactinomycin—melanoma	0.00104	0.00357	CcSEcCtD
Flucloxacillin—Decreased appetite—Carmustine—melanoma	0.00103	0.00355	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Carmustine—melanoma	0.00103	0.00353	CcSEcCtD
Flucloxacillin—Erythema multiforme—Docetaxel—melanoma	0.00102	0.0035	CcSEcCtD
Flucloxacillin—Constipation—Carmustine—melanoma	0.00102	0.0035	CcSEcCtD
Flucloxacillin—Dyspepsia—Temozolomide—melanoma	0.00101	0.00348	CcSEcCtD
Flucloxacillin—Abdominal pain—Dactinomycin—melanoma	0.001	0.00345	CcSEcCtD
Flucloxacillin—Body temperature increased—Dactinomycin—melanoma	0.001	0.00345	CcSEcCtD
Flucloxacillin—Hypersensitivity—Bleomycin—melanoma	0.001	0.00345	CcSEcCtD
Flucloxacillin—Decreased appetite—Temozolomide—melanoma	0.000998	0.00343	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Temozolomide—melanoma	0.000991	0.00341	CcSEcCtD
Flucloxacillin—Constipation—Temozolomide—melanoma	0.000982	0.00338	CcSEcCtD
Flucloxacillin—Feeling abnormal—Carmustine—melanoma	0.000979	0.00337	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Carmustine—melanoma	0.000972	0.00334	CcSEcCtD
Flucloxacillin—Immune system disorder—Docetaxel—melanoma	0.000971	0.00334	CcSEcCtD
Flucloxacillin—Feeling abnormal—Temozolomide—melanoma	0.000946	0.00326	CcSEcCtD
Flucloxacillin—Body temperature increased—Carmustine—melanoma	0.000939	0.00323	CcSEcCtD
Flucloxacillin—Abdominal pain—Carmustine—melanoma	0.000939	0.00323	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Temozolomide—melanoma	0.000939	0.00323	CcSEcCtD
Flucloxacillin—Hypersensitivity—Dactinomycin—melanoma	0.000936	0.00322	CcSEcCtD
Flucloxacillin—Dysgeusia—Docetaxel—melanoma	0.000916	0.00315	CcSEcCtD
Flucloxacillin—Urticaria—Temozolomide—melanoma	0.000912	0.00314	CcSEcCtD
Flucloxacillin—Abdominal pain—Temozolomide—melanoma	0.000908	0.00312	CcSEcCtD
Flucloxacillin—Body temperature increased—Temozolomide—melanoma	0.000908	0.00312	CcSEcCtD
Flucloxacillin—Hypersensitivity—Carmustine—melanoma	0.000876	0.00301	CcSEcCtD
Flucloxacillin—Diarrhoea—Dactinomycin—melanoma	0.000869	0.00299	CcSEcCtD
Flucloxacillin—Vomiting—Bleomycin—melanoma	0.000866	0.00298	CcSEcCtD
Flucloxacillin—Anaemia—Docetaxel—melanoma	0.000865	0.00298	CcSEcCtD
Flucloxacillin—Rash—Bleomycin—melanoma	0.000858	0.00295	CcSEcCtD
Flucloxacillin—Dermatitis—Bleomycin—melanoma	0.000858	0.00295	CcSEcCtD
Flucloxacillin—Hypersensitivity—Temozolomide—melanoma	0.000846	0.00291	CcSEcCtD
Flucloxacillin—Leukopenia—Docetaxel—melanoma	0.000838	0.00288	CcSEcCtD
Flucloxacillin—Diarrhoea—Carmustine—melanoma	0.000813	0.0028	CcSEcCtD
Flucloxacillin—Convulsion—Docetaxel—melanoma	0.000811	0.00279	CcSEcCtD
Flucloxacillin—Nausea—Bleomycin—melanoma	0.000809	0.00278	CcSEcCtD
Flucloxacillin—Vomiting—Dactinomycin—melanoma	0.000807	0.00278	CcSEcCtD
Flucloxacillin—Rash—Dactinomycin—melanoma	0.000801	0.00275	CcSEcCtD
Flucloxacillin—Myalgia—Docetaxel—melanoma	0.000797	0.00274	CcSEcCtD
Flucloxacillin—Arthralgia—Docetaxel—melanoma	0.000797	0.00274	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000791	0.00272	CcSEcCtD
Flucloxacillin—Dizziness—Carmustine—melanoma	0.000786	0.0027	CcSEcCtD
Flucloxacillin—Diarrhoea—Temozolomide—melanoma	0.000786	0.0027	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Docetaxel—melanoma	0.000764	0.00263	CcSEcCtD
Flucloxacillin—Dizziness—Temozolomide—melanoma	0.000759	0.00261	CcSEcCtD
Flucloxacillin—Vomiting—Carmustine—melanoma	0.000756	0.0026	CcSEcCtD
Flucloxacillin—Nausea—Dactinomycin—melanoma	0.000754	0.00259	CcSEcCtD
Flucloxacillin—Rash—Carmustine—melanoma	0.000749	0.00258	CcSEcCtD
Flucloxacillin—Nervous system disorder—Docetaxel—melanoma	0.000749	0.00258	CcSEcCtD
Flucloxacillin—Dermatitis—Carmustine—melanoma	0.000749	0.00258	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Docetaxel—melanoma	0.000748	0.00257	CcSEcCtD
Flucloxacillin—Headache—Carmustine—melanoma	0.000744	0.00256	CcSEcCtD
Flucloxacillin—Skin disorder—Docetaxel—melanoma	0.000742	0.00255	CcSEcCtD
Flucloxacillin—Vomiting—Temozolomide—melanoma	0.00073	0.00251	CcSEcCtD
Flucloxacillin—Rash—Temozolomide—melanoma	0.000724	0.00249	CcSEcCtD
Flucloxacillin—Dermatitis—Temozolomide—melanoma	0.000723	0.00249	CcSEcCtD
Flucloxacillin—Headache—Temozolomide—melanoma	0.000719	0.00247	CcSEcCtD
Flucloxacillin—Nausea—Carmustine—melanoma	0.000706	0.00243	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Docetaxel—melanoma	0.000696	0.00239	CcSEcCtD
Flucloxacillin—Nausea—Temozolomide—melanoma	0.000682	0.00235	CcSEcCtD
Flucloxacillin—Dyspepsia—Docetaxel—melanoma	0.000672	0.00231	CcSEcCtD
Flucloxacillin—Decreased appetite—Docetaxel—melanoma	0.000664	0.00228	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Docetaxel—melanoma	0.000659	0.00227	CcSEcCtD
Flucloxacillin—Constipation—Docetaxel—melanoma	0.000653	0.00225	CcSEcCtD
Flucloxacillin—Feeling abnormal—Docetaxel—melanoma	0.000629	0.00217	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Docetaxel—melanoma	0.000625	0.00215	CcSEcCtD
Flucloxacillin—Abdominal pain—Docetaxel—melanoma	0.000604	0.00208	CcSEcCtD
Flucloxacillin—Body temperature increased—Docetaxel—melanoma	0.000604	0.00208	CcSEcCtD
Flucloxacillin—Hypersensitivity—Docetaxel—melanoma	0.000563	0.00194	CcSEcCtD
Flucloxacillin—Diarrhoea—Docetaxel—melanoma	0.000523	0.0018	CcSEcCtD
Flucloxacillin—Dizziness—Docetaxel—melanoma	0.000505	0.00174	CcSEcCtD
Flucloxacillin—Cloxacillin—ALB—melanoma	0.000488	0.0263	CrCbGaD
Flucloxacillin—Vomiting—Docetaxel—melanoma	0.000486	0.00167	CcSEcCtD
Flucloxacillin—Rash—Docetaxel—melanoma	0.000482	0.00166	CcSEcCtD
Flucloxacillin—Dermatitis—Docetaxel—melanoma	0.000481	0.00166	CcSEcCtD
Flucloxacillin—Headache—Docetaxel—melanoma	0.000478	0.00165	CcSEcCtD
Flucloxacillin—Nausea—Docetaxel—melanoma	0.000454	0.00156	CcSEcCtD
Flucloxacillin—Ampicillin—ALB—melanoma	0.000388	0.0209	CrCbGaD
